One third of all approved drugs target the same family of receptors: the G-Protein-Coupled Receptors (GPCRs). Now, researchers have expanded the known network of peptides that activate GPCRs by 19 percent.
from Top Health News -- ScienceDaily https://ift.tt/2Nb4Hah
No comments:
Post a Comment